Nonalcoholic fatty liver disease (NAFLD) is recognized as the leading cause of chronic liver
disease in adults and children. NAFLD encompasses a spectrum of liver injuries ranging …

Non‐alcoholic fatty liver disease (NAFLD), the most common chronic liver disease in the
Western world, is tightly associated with obesity and metabolic syndrome. NAFLD entails an …

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) affects up to 30% of the
population and signifies increased risk of liver fibrosis and cirrhosis, type 2 diabetes, and …

Background & Aims Aerobic exercise reduces liver fat and visceral adipose tissue (VAT).
However, there is limited data from randomized trials to inform exercise programming …

Objective Knowledge of the epidemiology of non-alcoholic fatty liver disease (NAFLD) is
incomplete because liver biopsy cannot be performed on the general population to assess …

A theoretical triglyceride model was developed for in vivo human liver fat 1H MRS
characterization, using the number of double bonds ( CH CH), number of methylene …

Weight loss remains the most common therapy advocated for reducing hepatic lipid in
obesity and nonalcoholic fatty liver disease. Yet, reduction of body weight by lifestyle …

Purpose To prospectively compare an investigational version of a complex-based chemical
shift–based fat fraction magnetic resonance (MR) imaging method with MR spectroscopy for …

BACKGROUND & AIMS: Despite increasing use of various imaging examinations for non-
invasive assessment of hepatic steatosis (HS), their relative accuracy is unknown. The …

BACKGROUND & AIMS: In animal studies, expression of hepatitis B virus (HBV) proteins
causes hepatic steatosis. We aimed to study the prevalence of fatty liver in people with and …